GSG Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.56M Sell
9,672
-284
-3% -$74.9K 0.54% 32
2026
Q2
$2.53M Buy
9,956
+460
+5% +$107K 0.56% 32
2026
Q1
$2.32M Buy
9,496
+133
+1% +$31K 0.6% 26
2025
Q4
$1.94M Buy
9,363
+225
+2% +$44.5K 0.5% 28
2025
Q3
$1.7M Buy
9,138
+254
+3% +$43.5K 0.45% 33
2025
Q2
$1.36M Buy
8,884
+3,701
+71% +$569K 0.39% 37
2025
Q1
$782K Buy
5,183
+367
+8% +$57.4K 0.26% 49
2024
Q4
$696K Sell
4,816
-1,157
-19% -$179K 0.22% 54
2024
Q3
$968K Buy
5,973
+257
+4% +$40.9K 0.32% 40
2024
Q2
$837K Buy
5,716
+5
+0.1% +$744 0.3% 44
2024
Q1
$881K Buy
5,711
+190
+3% +$30.2K 0.32% 41
2023
Q4
$889K Buy
5,521
+1,686
+44% +$259K 0.33% 40
2023
Q3
$597K Buy
+3,835
New +$633K 0.29% 43

Other funds holding JNJ

GSG Advisors's JNJ Position: Q3 2026 in Review

GSG Advisors reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q3 2026, selling an estimated $74.9K and leaving 9,672 shares worth $2.56M. The position accounts for 0.54% of the portfolio, ranked #32.

GSG Advisors first reported a position in JNJ in Q3 2023 and has held it in 13 quarters since. 3,821 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • GSG Advisors held 9,672 shares of Johnson & Johnson worth $2.56M as of Q3 2026.
  • GSG Advisors sold 284 Johnson & Johnson shares in Q3 2026, an estimated $74.9K.
  • Johnson & Johnson made up 0.54% of GSG Advisors's portfolio in Q3 2026, its #32 holding.
  • GSG Advisors first reported a position in Johnson & Johnson in Q3 2023 and has held it in 13 quarters since.
  • 3,821 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on GSG Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.